P2Y14 Receptor as a Target for Neutrophilia Attenuation in Severe COVID-19 Cases: From Hematopoietic Stem Cell Recruitment and Chemotaxis to Thrombo‐inflammation

The global SARS-CoV-2 pandemic starting in 2019 has already reached more than 2.3 million deaths. Despite the scientific community’s efforts to investigate the COVID-19 disease, a drug for effectively treating or curing patients yet needs to be discovered. Hematopoietic stem cells (HSC) differentiat...

Descripción completa

Detalles Bibliográficos
Autores principales: Lintzmaier Petiz, Lyvia, Glaser, Talita, Scharfstein, Julio, Ratajczak, Mariusz Z., Ulrich, Henning
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7877512/
https://www.ncbi.nlm.nih.gov/pubmed/33575962
http://dx.doi.org/10.1007/s12015-021-10129-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7877512/
https://www.ncbi.nlm.nih.gov/pubmed/33575962
http://dx.doi.org/10.1007/s12015-021-10129-7

Ejemplares similares